Viewing nowNebistole Tablet 5 mg (Nebivolol Hydrochloride)
Nebivolol Hydrochloride 5.45mg
Tablet · Prescription medication
Ellison Pharmaceutical Co., Ltd.

MFDS item code 201208083 · Approved 2012.11.09 · Insurance code 620500090
Treatment of essential hypertension; adjunctive treatment of chronic heart failure in patients aged 70 years or older
This medication is used to manage essential hypertension and also assists in the standard treatment of elderly patients (aged 70 and over) with stable chronic heart failure. It is used to stabilize blood pressure and improve heart function.
1. Essential hypertension 1) Adults Administer nebivolol 5mg orally once daily at the same time each day. The blood pressure-lowering effect usually appears after 1~2 weeks of treatment and may, in some cases, appear after 4 weeks. It may be taken with food. 2) Patients with renal impairment The initial dose is nebivolol 2.5mg orally once daily. If necessary, the daily dose may be increased to 5mg. 3) Elderly patients The initial dose in elderly patients aged 65 years or older is nebivolol 2.5mg once daily. If necessary, the daily dose may be increased to 5mg. Since clinical experience in patients aged 75 years or older is insufficient, administer with careful monitoring. 2. Chronic heart failure 1) Elderly patients aged 70 years or older This drug should be administered to patients with chronic stable heart failure who have had no acute heart failure during the previous 6 weeks, and doses of cardiovascular medicines such as diuretics, digoxin, ACE inhibitors, and angiotensin II receptor blockers should have been stabilized up to 2 weeks before starting this drug. Taking the patient's condition into account, gradually increase the dose at 1~2-week intervals until the optimal dose for each patient is reached. Begin treatment with nebivolol 1.25mg once daily and, if necessary, increase to 2.5mg once daily, 5mg once daily, and up to 10mg once daily. The maximum daily dose is 10mg. It may be taken with food. 2) Patients with renal impairment Since titration to the maximum tolerated dose is adjusted for each patient, dose adjustment is not required in patients with mild to moderate renal impairment. Do not administer to patients with severe renal impairment (serum creatinine≥250μmol/L), as there is no experience with its use in these patients.
This medication should not be used in certain patients. For example, it should not be administered to patients who are allergic to this medication, have bronchial asthma, metabolic acidosis, bradycardia, or severe heart failure or hypotension. Additionally, it is not suitable for patients with severe liver or kidney impairment, pregnant or breastfeeding women, and patients with specific genetic lactose intolerance. Caution is required when administering this medication to patients with chronic lung disease or heart failure, peripheral circulation disorders, thyroid dysfunction, and diabetes. Older adults should also be monitored carefully. During treatment, side effects such as skin rash, changes in vision, abnormal heart rhythms, headaches, dizziness, digestive issues, shortness of breath, and fatigue may occur, so any unusual symptoms should be reported to a healthcare professional immediately. It may be necessary to discontinue this medication before surgery, and abrupt discontinuation can worsen heart problems, so it must be reduced gradually according to a physician's instructions. This medication can interact with other drugs, so special caution is needed when taken in conjunction with calcium channel blockers, antiarrhythmics, central nervous system medications, and diabetes medications. If pregnant or breastfeeding, it should be avoided as it can cause side effects in the fetus or newborn. Safety and effectiveness have not been confirmed for children under 18 years, so it is not recommended. Elderly patients should start at a low dose and be administered cautiously; dosage should be gradually adjusted as necessary. In case of overdose, severe bradycardia, hypotension, and respiratory distress may occur, requiring immediate medical treatment.
Not everyone experiences these, and they can vary from person to person.
This medication should be stored in a sealed container to prevent exposure to air or moisture, and it is important to keep it at a temperature between 1 and 30 degrees Celsius. Maintaining proper storage temperature will safely preserve the medication's effectiveness.
White round tablets
30 tablets/bottle, 300 tablets/bottle, 500 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowNebivolol Hydrochloride 5.45mg
Tablet · Prescription medication
Ellison Pharmaceutical Co., Ltd.

Nebivolol Hydrochloride 5.45mg
Tablet · Prescription medication
Chodang Pharmaceutical Co., Ltd.

Nebivolol Hydrochloride 5.45mg
Tablet · Prescription medication
Hanol Bio Pharma Co., Ltd.

Nebivolol Hydrochloride 5.45mg
Tablet · Prescription medication
Youngjin Pharmaceutical Co., Ltd.

Nebivolol Hydrochloride 5.45mg
Tablet · Prescription medication
Dongkuk Pharmaceutical Co., Ltd.

Nebivolol Hydrochloride 5.45mg
Tablet · Prescription medication
Aju Pharmaceuticals Co., Ltd.

Nebivolol Hydrochloride 2.725mg
Tablet · Prescription medication
Erison Pharm Co., Ltd.

Nebivolol Hydrochloride 1.3625mg
Tablet · Prescription medication
Ellison Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.